Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer
Abstract
Objective: Patients with cancer have antibodies against tumour antigens. Characterising the antibody repertoire may provide insights into aberrant cellular mechanisms in cancer development, ultimately leading to novel diagnostic or therapeutic targets. The aim of this study was to characterise the antibody profiles in patients whose symptoms warranted colonoscopy, to see if there was a difference in patients with and without colorectal cancer. Methods: Patients were recruited from a colonoscopy clinic. Individual serum samples from 43 patients with colorectal cancer and 40 patients with no cancer on colonoscopy were profiled on a 37 830 clone recombinant human protein array. Antigen expression was evaluated by quantitative reverse transcription-PCR and by immunohistochemistry on tissue microarrays. Results: Using a sex- and age-matched training set, 18 antigens associated with cancer and 4 associated with the absence of cancer (pConclusions: It is demonstrated for the first time that screening high-density protein arrays identifies unique antibody profiles that discriminate between symptomatic patients with and without colorectal cancer. The differential expression of identified antigens suggests their involvement in aberrant cellular mechanisms in cancer.Keywords
This publication has 52 references indexed in Scilit:
- ATM Signaling Facilitates Repair of DNA Double-Strand Breaks Associated with HeterochromatinMolecular Cell, 2008
- Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinomaCancer Letters, 2008
- Physical and functional interactions between STAT3 and KAP1Oncogene, 2007
- Autoimmunity and tumor immunity induced by immune responses to mutations in selfNature Medicine, 2006
- Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease‐associated protein chipProteomics, 2006
- Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensJournal of Proteome Research, 2004
- Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapyInternational Journal of Colorectal Disease, 2004
- Genetic changes occurring in established tumors rapidly stimulate new antibody responsesProceedings of the National Academy of Sciences, 2003
- Fingerprinting the circulating repertoire of antibodies from cancer patientsNature Biotechnology, 2002
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002